Skip to main content
. 2021 Sep 23;11:18910. doi: 10.1038/s41598-021-98082-w

Figure 4.

Figure 4

2-Oxyglutarate prevents IMS32 cell death, mitochondrial dysfunction and ATP depletion under high-glucose pyruvate-starved conditions. (A) Cell viability at 24 h in the [Glc 5 mM/Pyr (+)] (blue), [Glc 5 mM/Pyr (−)] (yellow), [Glc 15 mM/Pyr (+)] (brown), [Glc 15 mM/Pyr (−)] (green), and [Glc 15 mM/Pyr (−)] supplemented with TCA cycle intermediates (red) groups was determined by MTS assay. (B) Time course of OCR in the [Glc 5 mM/Pyr (+)] (blue), [Glc 5 mM/Pyr (−)] (yellow), [Glc 100 mM/Pyr (+)] (brown), [Glc 100 mM/Pyr (−)] (green), and [Glc 100 mM/Pyr (−)/2-OG (+)] (red) groups measured by Extracellular Flux Analyzer and Cell MitoStress Test. (C) Mitochondrial ATP production under these five conditions was estimated by changes in OCR through sequential addition of oligomycin and FCCP. Values represent mean + SD from six (A) and 9–10 (B and C) experiments (individual values are depicted as circles, triangles, pluses, crosses and asterisks). (A and C) * P < 0.05, ** P < 0.01. (B) [Glc 100 mM/ Pyr (−)] compared with (a) all the other groups (P < 0.01), (b) [Glc 5 mM/Pyr (+)], [Glc 100 mM/ Pyr (+)], or [Glc 100 mM/Pyr (−)/2-OG (+)] (P < 0.01), (c) [Glc 100 mM/Pyr (−)/2-OG (+)] (P < 0.01) or [Glc 100 mM/ Pyr (+)] (P < 0.05), (d) [Glc 100 mM/Pyr (−)/2-OG (+)] (P < 0.01), and (e) [Glc 100 mM/ Pyr (+)] or [Glc 100 mM/Pyr (−)/2-OG (+)] (P < 0.01). Ac CoA, acetyl CoA; Cit, citrate; ISC, isocitrate; 2-OG, 2-oxyglutarate; Suc CoA, succinyl CoA; Suc, succinate; Fum, fumarate; Mai, malate; and OAA; oxaloacetate.